# Efficacy of probiotic supplementation in preventing Clostridioides difficile infection: an umbrella review of systematic reviews and meta-analysis

**Authors:** Wenci Chen, Xianjuan Pan, Jing Ji, Zhenhua Wu, Xinxin Lin

PMC · DOI: 10.3389/fnut.2026.1699223 · Frontiers in Nutrition · 2026-03-09

## TL;DR

This study reviews evidence that probiotics can reduce the risk of Clostridioides difficile infection, but the quality of evidence varies.

## Contribution

This umbrella review synthesizes multiple meta-analyses to evaluate the overall efficacy of probiotics in preventing CDI.

## Key findings

- Probiotics significantly reduced CDI risk with a pooled relative risk of 0.37.
- Multi-strain probiotics and those containing Saccharomyces boulardii showed significant benefits.
- The quality of evidence ranged from moderate to low, with minimal overlap among primary studies.

## Abstract

Clostridioides difficile infection (CDI) is a significant healthcare-associated infection. Probiotics have been proposed as a preventive strategy. This umbrella review synthesizes evidence from meta-analyses on the efficacy of probiotics in preventing CDI.

A comprehensive systematic search was conducted in PubMed, Scopus, Web of Science, Embase, and the Cochrane Library up to December 2025. To manage overlap, a single primary systematic review was selected per outcome. The methodological quality of included reviews was assessed using AMSTAR-2, and the certainty of evidence was graded. Pooled effect sizes were calculated using a random-effects model.

Sixteen systematic reviews and meta-analyses were included. The pooled relative risk (RR) from primary reviews indicated that probiotics significantly reduced CDI risk (RR = 0.37; 95% CI: 0.32 to 0.42; I2 = 0%). Multi-strain probiotics and formulations containing Saccharomyces boulardii showed significant benefits. The quality of evidence ranged from moderate to low, and overlap among primary studies was minimal (Corrected Covered Area = 15%).

Probiotic supplementation is associated with a reduced risk of CDI. However, given the variable methodological quality of the underlying evidence, these findings should be interpreted with caution. Population-specific and strain-specific effects require further investigation.

## Full-text entities

- **Diseases:** CDI (MESH:D003015), infection (MESH:D007239)
- **Species:** Saccharomyces boulardii [taxon 252598]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13006325/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13006325/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC13006325/full.md

---
Source: https://tomesphere.com/paper/PMC13006325